MedTrace Logo

Immune Reconstitution in Stem Cell Transplant Recipients

NCT02129543 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2026-01-05

No results posted yet for this study

Summary

This specimen collection lab protocol will allow the investigators to prospectively study immune reconstitution in patients being treated for hematologic disorders and immune factors affecting graft versus host disease in stem-cell transplant (SCT) patients.

Conditions

Interventions

PROCEDURE

Blood Draw

Whole blood samples will be collected from study subjects for immune cell and plasma analysis per protocol.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Jay Spiegel, MD · University of Miami

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-15
Primary Completion
2026-12-15
Completion
2026-12-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02129543 on ClinicalTrials.gov